Market Cap 7.46M
Revenue (ttm) 0.00
Net Income (ttm) 30.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 834,500
Avg Vol 149,508
Day's Range N/A - N/A
Shares Out 10.74M
Stochastic %K 75%
Beta 0.46
Analysts Strong Buy
Price Target N/A

Company Profile

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other soli...

Industry: Biotechnology
Sector: Healthcare
Phone: 917 595 2850
Fax: 917 595 2851
Address:
3960 Howard Hughes Parkway, Suite 500, Las Vegas, United States
green_going_up
green_going_up May. 13 at 4:37 AM
$QCLS $PMCB using Lightsolver technology, developing the first light-based computing system to blockchain! Fyi, Lightsolver recently partnered with Boeing. And, the use of the Lightsolver technology is for crypto and blockchains. Just an fyi, nearly anything and everything transactional that requires settlement and / or verification is blockchainable. All the computations that Lightsolver can solve, across any industry, can be put on a blockchain.
0 · Reply
Natslover
Natslover May. 12 at 4:29 PM
$QCLS I’m wondering if someone knows something because $PMCB also has unusually high volume today. We have seen this before though - just interesting it’s happening on a down day in the market
0 · Reply
ACInvestorBlog
ACInvestorBlog May. 12 at 3:40 PM
$PMCB breakout watch over 80c next pivot lies at 1.2 (Cash rich company Net Cash/Sh:1.74 )
1 · Reply
SuperGreenToday
SuperGreenToday May. 5 at 9:15 PM
$PMCB Share Price: $0.74 Contract Selected: Oct 16, 2026 $2.5 Calls Buy Zone: $0.08 – $0.09 Target Zone: $0.13 – $0.16 Potential Upside: 58% ROI Time to Expiration: 163 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jboy92860
jboy92860 May. 4 at 1:56 AM
$PMCB I have owned this for over 10 years with FDA promises and splits that have destroyed my investment…..This is complete garbage.
1 · Reply
Value_Trader_777
Value_Trader_777 Apr. 22 at 6:07 PM
$PMCB should be getting an update on their meeting with the FDA by mid May the latest… then if the FDA fully lifts the hold on their Pancreatic Cancer trial expect a moonshot
1 · Reply
luminouslumens
luminouslumens Apr. 15 at 7:48 PM
$QCLS $PMCB with quantum + semis ripping, bout time for another run, no? 🧐
0 · Reply
KingChad
KingChad Apr. 15 at 3:56 PM
$PMCB Glad I bought in. This could chase to $1 or more.
0 · Reply
KingChad
KingChad Apr. 14 at 7:21 PM
$PMCB could pop if it gets some volume. I like it.
0 · Reply
Natslover
Natslover Apr. 14 at 2:36 PM
$PMCB Is it riding with $QCLS? Interesting early volume here
0 · Reply
Latest News on PMCB
Largest borrow rate increases among liquid names

2025-12-31T13:45:13.000Z - 4 months ago

Largest borrow rate increases among liquid names

BTQ CIFR FJET GRRR IRE KDK SLS


Largest borrow rate increases among liquid names

2025-12-15T13:45:16.000Z - 5 months ago

Largest borrow rate increases among liquid names

DUST ITUB MSOS NNE RVPH STM XME


MyMD Pharmaceuticals Secures Strategic Investments

May 21, 2024, 9:00 AM EDT - 2 years ago

MyMD Pharmaceuticals Secures Strategic Investments


PharmaCyte Biotech Announces Final Results of Tender Offer

Jun 15, 2023, 9:15 AM EDT - 3 years ago

PharmaCyte Biotech Announces Final Results of Tender Offer


PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

Jul 21, 2022, 8:30 AM EDT - 4 years ago

PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study


green_going_up
green_going_up May. 13 at 4:37 AM
$QCLS $PMCB using Lightsolver technology, developing the first light-based computing system to blockchain! Fyi, Lightsolver recently partnered with Boeing. And, the use of the Lightsolver technology is for crypto and blockchains. Just an fyi, nearly anything and everything transactional that requires settlement and / or verification is blockchainable. All the computations that Lightsolver can solve, across any industry, can be put on a blockchain.
0 · Reply
Natslover
Natslover May. 12 at 4:29 PM
$QCLS I’m wondering if someone knows something because $PMCB also has unusually high volume today. We have seen this before though - just interesting it’s happening on a down day in the market
0 · Reply
ACInvestorBlog
ACInvestorBlog May. 12 at 3:40 PM
$PMCB breakout watch over 80c next pivot lies at 1.2 (Cash rich company Net Cash/Sh:1.74 )
1 · Reply
SuperGreenToday
SuperGreenToday May. 5 at 9:15 PM
$PMCB Share Price: $0.74 Contract Selected: Oct 16, 2026 $2.5 Calls Buy Zone: $0.08 – $0.09 Target Zone: $0.13 – $0.16 Potential Upside: 58% ROI Time to Expiration: 163 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jboy92860
jboy92860 May. 4 at 1:56 AM
$PMCB I have owned this for over 10 years with FDA promises and splits that have destroyed my investment…..This is complete garbage.
1 · Reply
Value_Trader_777
Value_Trader_777 Apr. 22 at 6:07 PM
$PMCB should be getting an update on their meeting with the FDA by mid May the latest… then if the FDA fully lifts the hold on their Pancreatic Cancer trial expect a moonshot
1 · Reply
luminouslumens
luminouslumens Apr. 15 at 7:48 PM
$QCLS $PMCB with quantum + semis ripping, bout time for another run, no? 🧐
0 · Reply
KingChad
KingChad Apr. 15 at 3:56 PM
$PMCB Glad I bought in. This could chase to $1 or more.
0 · Reply
KingChad
KingChad Apr. 14 at 7:21 PM
$PMCB could pop if it gets some volume. I like it.
0 · Reply
Natslover
Natslover Apr. 14 at 2:36 PM
$PMCB Is it riding with $QCLS? Interesting early volume here
0 · Reply
slick3333
slick3333 Apr. 9 at 1:12 AM
$PMCB when split date?
1 · Reply
_RG1_
_RG1_ Apr. 7 at 7:26 PM
$PMCB Just a matter of time for a boom up or down let’s hope is up
0 · Reply
paulengman
paulengman Apr. 6 at 12:23 AM
$PMCB Why did my Dad buy this stock for me 10 years ago? He acted like they had a cure for cancer or something...what a loser.
0 · Reply
focafoca99
focafoca99 Apr. 3 at 8:45 PM
$PMCB annual meeting approved a reverse split authorization and added 2 million shares to the 2022 equity plan pool.
0 · Reply
matans844
matans844 Mar. 30 at 6:57 PM
$PMCB $QCLS LOL INFINITY!!
0 · Reply
matans844
matans844 Mar. 28 at 1:26 AM
$QCLS Do you actually think they haven’t started dilution? Ask @KKEE122 for a joint walkthrough of the $PMCB earnings report, if he actually knows how to read that. Focus on current QCLS stock holdings and how they have changed over time. By the way, PMCB is set to be delisted in June because it is below $1. I repeat: The amount of incompetence the current leadership QCLS (and PMCB) has is unmatched - playing the dumbest games possible to increase ownership on a sinking ship instead of sharing ownership in a questionable, yet possibly promising, new ship.
0 · Reply
matans844
matans844 Mar. 27 at 5:08 PM
$PMCB $QCLS Replying? When have you ever truly replied to anyone here? You are a troll. You cannot post without gigantic GIFs. You have not provided a single meaningful piece of information about this company or stock during all the time you have been active on StockTwits (and I went over all your messages here). At this point, it makes perfect sense that you are an insider because you are as useful for this stock as they are. It is fitting that you fade to silence as the stock breaks another multi-month low. Pathetic. Stay there.
0 · Reply
KKEE122
KKEE122 Mar. 27 at 4:56 PM
$PMCB $QCLS I’ve decided to stop replying to you completely, because there’s no point anymore. You’re genuinely obsessed with this and you insist on turning every discussion into a personal drama about yourself and your loss. Every time you come back with long essays and demand answers, it all ends up revolving around you. There’s no benefit in continuing like this. I’m out. You can keep performing on your own
0 · Reply
matans844
matans844 Mar. 27 at 4:16 PM
$PMCB $QCLS What a surprise - after demonstrating he does not know how to use a calculator, the oracle/insider/clown has yet to answer one question about the company. But I’m the one with the essays. I challenge any of you to find me one alpha this guy provided on this company. He was asked questions many times - gave zero insight, zero alpha, zero anything. In fact, I challenge any of you to find anyone in this entire thread who provided insight on the company or on the stock other than me.
0 · Reply
KKEE122
KKEE122 Mar. 27 at 4:02 PM
$PMCB $QCLS Still obsessed with me? Bro, you’re the one who keeps coming back every few hours writing essays. You lost money on the long, flipped to short... then you come demanding employee names? Honestly, I’m only feeling sorry for you because of your big loss. If you want a serious discussion about the company, start by being honest about your own trades. Until then, keep performing
1 · Reply
matans844
matans844 Mar. 27 at 3:16 PM
$PMCB $QCLS The clown show continues. My blood samples will be sent momentarily, with my autograph. Jesus, are you going to answer one serious question about this company or stock, or do you want to keep this obsession with me going? Give me the name of one employee at the company you think is doing a good job, and explain what he is doing and why it is good.
0 · Reply
KKEE122
KKEE122 Mar. 27 at 3:07 PM
$PMCB $QCLS Honestly, I don’t believe these calculations. You lost ~20% on the long, then shorted and ended with only +1.27% overall? Bro, this story doesn’t add up. Either you didn’t sell your entire long position, or the short size was much bigger than you’re saying, or you’re just adjusting the numbers to make it look better. Turning a 20% loss into a tiny +1.27% profit over such a small price move is really hard to believe. The SuperGrok numbers look neat, but the overall story has clear contradictions. If you’re being honest, show the real details: position sizes, exact timing, and full calculations. Right now, it looks more like coping with numbers than actual math. Keep going, I’m still enjoying the story.
3 · Reply